All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q2 report for BIOMARIN PHARMACEUTICAL, INC. on July 21, 2025, reporting $10,000 in lobbying income.
Lobbying for BIOMARIN PHARMACEUTICAL, INC. · Pharmaceutical company.
Amended
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
4
Lobbying activity
2
General Medicare and Medicaid Issues.
Prescription drug payment reform. Pharmaceutical supply chain.